Jong Woo Lee

University of Seoul — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index4.7kcitations214works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(27), Cancer-related Molecular Pathways(24), Cell death mechanisms and regulation(23), Microtubule and mitosis dynamics(22), ZnO doping and properties(21)

Publications214 total

Spatially Controlled Doping via High Diffusion Dynamics in Perovskite Nanocrystals for Efficient and Stable CO <sub>2</sub> Reduction Photocatalysis
ACS Applied Materials & Interfaces·2025· 1 cited
Author Correction: Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry
Scientific Reports·2025Open Access
Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry
Scientific Reports·2025· 1 citedOpen Access
Designing multiple charge carrier separation pathways in core-type near infrared colloidal nanocrystal for broadband photodetector
RSC Advances·2025· 1 citedOpen Access
Investigation of the Relationship between Quantum Yield, Charge-Transfer State, and Structure of the Ligands in Red-Emitting Heteroleptic Iridium(III) Complexes
The Journal of Physical Chemistry A·2024· 2 cited
Establishing Theoretical Foundation for Narrative Assessment in English Language Teaching
The Korean Society for Teaching English Literature·2023
Alcoholic Solvent-Mediated Excited-State Proton Transfer Dynamics of a Novel Dihydroxynaphthalene Dye
The Journal of Physical Chemistry A·2023· 3 cited
Using Machine Learning to Identify Metabolite Spectral Patterns that Reflect Outcome after Cardiac Arrest
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Abstract 542: Synthetic lethal targeting of AURKA in head and neck squamous cell carcinoma
Cancer Research·2023
Abstract 1563: Concomitant inhibition of Aurora kinase A and WEE1 kinases results in synergistic tumor control and heightens DNA replication stress in head and neck and lung carcinomas
Cancer Research·2023
Supplementary Figure S2 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S5 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary figure and table legends from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S4 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S3 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S6 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Data from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Table S4 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S4 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
Supplementary Figure S3 from Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Nam Jin Yoo(24), Sug Hyung Lee(24), Suk Woo Nam(22), Jung Young Lee(20), Young Hwa Soung(19), Won Sang Park(18), Seong Keun Kim(16), Su Young Kim(15), Sang Ho Kim(12), Hong Sug Kim(8), Kisu Lee(8), Haejun Yu(8), Doyk Hwang(8), Jong‐Heun Lee(7), Chang Jae Kim(6), Gi Rim Han(6), Jik Young Park(5), Jung Young Lee(4), Jyongsik Jang(4), Yong Gu Cho(4)